Brain and Blood Vessel Imaging for Ischemic Stroke in Patients with Covid-19—Data from the Literature and Clinical Cases

1 Coupland AP, Thapar A, Qureshi MI, Jenkins H, Davies AH. The definition of stroke. J R Soc Med. 2017;110(1):9–12. http://dx.doi.org/10.1177/0141076816680121 Search in Google Scholar

2 Chugh C. Acute ischemic stroke: Management approach. Indian J Crit Care Med. 2019;23(Suppl 2):S140–6. http://dx.doi.org/10.5005/jp-journals-10071-23192 Search in Google Scholar

3 Patil S, Rossi R, Jabrah D, Doyle K. Detection, diagnosis and treatment of acute ischemic stroke: Current and future perspectives. Front Med Technol. 2022;4:748949. http://dx.doi.org/10.3389/fmedt.2022.748949 Search in Google Scholar

4 French BR, Boddepalli RS, Govindarajan R. Acute ischemic stroke: Current status and future directions. Mo Med. 2016;113(6):480–6. Search in Google Scholar

5 Akbarzadeh MA, Sanaie S, Kuchaki Rafsanjani M, Hosseini MS. Role of imaging in early diagnosis of acute ischemic stroke: a literature review. Egypt J Neurol Psychiatr Neurosurg. 2021;57(1). http://dx.doi.org/10.1186/s41983-021-00432-y Search in Google Scholar

6 El-Koussy M, Schroth G, Brekenfeld C, Arnold M. Imaging of acute ischemic stroke. Eur Neurol. 2014;72(5–6):309–16. http://dx.doi.org/10.1159/000362719 Search in Google Scholar

7 Sui B, Gao P. Imaging evaluation of acute ischemic stroke. J Int Med Res. 2020;48(1):300060518802530. http://dx.doi.org/10.1177/0300060518802530 Search in Google Scholar

8 Mackman N, Antoniak S, Wolberg AS, Kasthuri R, Key NS. Coagulation abnormalities and thrombosis in patients infected with SARS-CoV-2 and other pandemic viruses. Arterioscler Thromb Vasc Biol. 2020;40(9):2033–44. http://dx.doi.org/10.1161/ATVBAHA.120.314514 Search in Google Scholar

9 Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2013;13(1):34–45. http://dx.doi.org/10.1038/nri3345 Search in Google Scholar

10 Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–90. http://dx.doi.org/10.1001/jamaneurol.2020.1127 Search in Google Scholar

11 Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY, et al. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020;91(8):889–91. http://dx.doi.org/10.1136/jnnp-2020-323586 Search in Google Scholar

12 Qin C, Zhou L, Hu Z, Yang S, Zhang S, Chen M, et al. Clinical characteristics and outcomes of COVID-19 patients with a history of stroke in Wuhan, China. Stroke. 2020;51(7):2219–23. http://dx.doi.org/10.1161/STROKEAHA.120.030365 Search in Google Scholar

13 Majidi S, Fifi JT, Ladner TR, Lara-Reyna J, Yaeger KA, Yim B, et al. Emergent large vessel occlusion stroke during New York City’s COVID-19 outbreak: Clinical characteristics and paraclinical findings. Stroke. 2020;51(9):2656–63. http://dx.doi.org/10.1161/STROKEAHA.120.030397 Search in Google Scholar

14 Violi F, Pastori D, Cangemi R, Pignatelli P, Loffredo L. Hypercoagulation and antithrombotic treatment in Coronavirus 2019: A new challenge. Thromb Haemost . 2020;120(6):949–56. http://dx.doi.org/10.1055/s-0040-1710317 Search in Google Scholar

15 Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GDO, Fowkes FGR. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study: The Edinburgh Artery Study. Circulation . 2007;115(16):2119–27. http://dx.doi.org/10.1161/CIRCULATIONAHA.106.635029 Search in Google Scholar

16 Kvernland A, Kumar A, Yaghi S, Raz E, Frontera J, Lewis A, et al. Anticoagulation use and hemorrhagic stroke in SARS-CoV-2 patients treated at a New York healthcare system. Neurocrit Care . 2021;34(3):748–59. http://dx.doi.org/10.1007/s12028-020-01077-0 Search in Google Scholar

17 Sweid A, Hammoud B, Weinberg JH, Oneissi M, Raz E, Shapiro M, et al. Letter: Thrombotic neurovascular disease in COVID-19 patients: Thrombotic neurovascular disease in COVID-19 patients. Neurosurgery. 2020;87(3):E400–6. http://dx.doi.org/10.1093/neuros/nyaa254 Search in Google Scholar

18 Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, et al. Large-vessel stroke as a presenting feature of covid-19 in the young. N Engl J Med . 2020;382(20):e60. http://dx.doi.org/10.1056/NEJMc2009787 Search in Google Scholar

19 de Lorenzo A, Espinel L, Revilla Á, Corbalán T, Martins J, Naya MT, et al. Ischaemic stroke associated with COVID-19 in dialysis patients. Nefrol (Engl Ed) . 2021;41(5):590–3. http://dx.doi.org/10.1016/j.nefroe.2021.11.002 Search in Google Scholar

20 Ozel T, Erdem N, Ünal A, Yalçın A, İnan D, Ilhanli N, et al. Neurological manifestations and mortality in hospitalized coronavirus disease 2019 patients. Neurol Sci Neurophysiol. 2022;39(3):138. http://dx.doi.org/10.4103/nsn.nsn_117_21 Search in Google Scholar

21 Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762–8. http://dx.doi.org/10.1093/cid/ciaa248 Search in Google Scholar

22 Steardo L, Steardo L Jr, Zorec R, Verkhratsky A. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol (Oxf) . 2020;229(3):e13473. http://dx.doi.org/10.1111/apha.13473 Search in Google Scholar

23 Xia H, Sriramula S, Chhabra KH, Lazartigues E. Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension. Circ Res. 2013;113(9):1087–96. http://dx.doi.org/10.1161/CIRCRESAHA.113.3018 Search in Google Scholar

24 Fraga-Silva RA, Da Silva DG, Montecucco F, Mach F, Stergiopulos N, da Silva RF, et al. The angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis: a potential target for treating thrombotic diseases. Thromb Haemost . 2012;108(6):1089–96. http://dx.doi.org/10.1160/TH12-06-0396 Search in Google Scholar

25 Becker RC. COVID-19-associated vasculitis and vasculopathy. J Thromb Thrombolysis. 2020;50(3):499–511. http://dx.doi.org/10.1007/s11239-020-02230-4 Search in Google Scholar

26 Takasu S, Ariizumi M, Matsumoto S, Nakagawa H, Iwadate K. Cerebral venous sinus thrombosis associated with COVID-19: an autopsy case report. Forensic Sci Med Pathol . 2022;18(1):80–5. http://dx.doi.org/10.1007/s12024-022-00458-5 Search in Google Scholar

27 Belani P, Schefflein J, Kihira S, Rigney B, Delman BN, Mahmoudi K, et al. COVID-19 is an independent risk factor for acute ischemic stroke. AJNR Am J Neuroradiol . 2020;41(8):1361–4. http://dx.doi.org/10.3174/ajnr.A6650 Search in Google Scholar

28 Yang XH, Deng W, Tong Z, Liu YX, Zhang LF, Zhu H, et al. Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection. Comp Med. 2007;57(5):450–9. Search in Google Scholar

29 Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol . 2008;82(15):7264–75. http://dx.doi.org/10.1128/JVI.00737-08 Search in Google Scholar

30 Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11(7):995–8. http://dx.doi.org/10.1021/acschemneuro.0c00122 Search in Google Scholar

31 Yang J, Petitjean SJL, Koehler M, Zhang Q, Dumitru AC, Chen W, et al. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Nat Commun . 2020;11(1). http://dx.doi.org/10.1038/s41467-020-18319-6 Search in Google Scholar

32 Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, et al. SARS-CoV-2 and stroke in a New York healthcare system. Stroke. 2020;51(7):2002–11. http://dx.doi.org/10.1161/STROKEAHA.120.030335 Search in Google Scholar

33 Siegler JE, Cardona P, Arenillas JF, Talavera B, Guillen AN, Chavarría-Miranda A, et al. Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry. Int J Stroke . 2021;16(4):437–47. http://dx.doi.org/10.1177/1747493020959216 Search in Google Scholar

34 Cavallieri F, Marti A, Fasano A, Dalla Salda A, Ghirarduzzi A, Moratti C, et al. Prothrombotic state induced by COVID-19 infection as trigger for stroke in young patients: A dangerous association. eNeurologicalSci . 2020;20(100247):100247. http://dx.doi.org/10.1016/j.ensci.2020.100247 Search in Google Scholar

35 Morey JR, Kim BD, Redlener M, Zhang X, Marayati NF, Matsoukas S, et al. Updated New York city emergency medical services acute stroke triage protocol reduces interfacility transfers and time to endovascular thrombectomy for emergent large vessel occlusion stroke patients. J Stroke . 2022;24(3):417–20. http://dx.doi.org/10.5853/jos.2022.01200 Search in Google Scholar

36 Rudilosso S, Laredo C, Vera V, Vargas M, Renú A, Llull L, et al. Acute stroke care is at risk in the era of COVID-19: Experience at a Comprehensive Stroke Center in Barcelona: Experience at a Comprehensive Stroke Center in Barcelona. Stroke . 2020;51(7):1991–5. http://dx.doi.org/10.1161/STROKEAHA.120.030329 Search in Google Scholar

37 White TG, Martinez G, Wang J, Gribko M, Boltyenkov A, Arora R, et al. Impact of the COVID-19 pandemic on acute ischemic stroke presentation, treatment, and outcomes. Stroke Res Treat . 2021;2021:8653396. http://dx.doi.org/10.1155/2021/8653396 Search in Google Scholar

38 Zaaqoq AM, Griffee MJ, Kelly TL, Fanning J, Heinsar S, Suen J, et al. Cerebrovascular Complications of COVID-19 on Venovenous Extracorporeal Membrane Oxygenation. Research Square. 2022. http://dx.doi.org/10.21203/rs.3.rs-1785832/v1 Search in Google Scholar

39 Kihira S, Schefflein J, Mahmoudi K, Rigney B, N Delman B, Mocco J, et al. Association of Coronavirus disease (COVID-19) with large vessel occlusion strokes: A case-control study. AJR Am J Roentgenol. 2021;216(1):150–6. http://dx.doi.org/10.2214/AJR.20.23847 Search in Google Scholar

40 Ornello R, Degan D, Tiseo C, Di Carmine C, Perciballi L, Pistoia F, et al. Distribution and temporal trends from 1993 to 2015 of ischemic stroke subtypes: A systematic review and meta-analysis: A systematic review and meta-analysis. Stroke. 2018;49(4):814–9. http://dx.doi.org/10.1161/STROKEAHA.117.020031 Search in Google Scholar

41 Morassi M, Bagatto D, Cobelli M, D’Agostini S, Gigli GL, Bnà C, et al. Stroke in patients with SARS-CoV-2 infection: case series. J Neurol . 2020;267(8):2185–92. http://dx.doi.org/10.1007/s00415-020-09885-2 Search in Google Scholar

42 Tan YK, Goh C, Leow AST, Tambyah PA, Ang A, Yap ES, et al. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thrombolysis . 2020;50(3):587–95. http://dx.doi.org/10.1007/s11239-020-02228-y Search in Google Scholar

43 John S, Kesav P, Mifsud VA, Piechowski-Jozwiak B, Dibu J, Bayrlee A, et al. Characteristics of large-vessel occlusion associated with COVID-19 and ischemic stroke. AJNR Am J Neuroradiol . 2020;41(12):2263–8. http://dx.doi.org/10.3174/ajnr.A6799 Search in Google Scholar

44 Amiri HA, Razavi AS, Tabrizi N, Cheraghmakani H, Baghbanian SM, Sedaghat-Chaijan M, et al. The effects of COVID-19 on patients with acute ischemic and hemorrhagic stroke. J Stroke Cerebrovasc Dis. 2022;31(7):106512. http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2022.106512 Search in Google Scholar

45 Sojka M, Drelich-Zbroja A, Kuczyńska M, Cheda M, Dąbrowska I, Kopyto E, et al. Ischemic and hemorrhagic cerebrovascular events related to COVID-19 coagulopathy and hypoxemia. Int J Environ Res Public Health. 2022;19(18):11823. http://dx.doi.org/10.3390/ijerph191811823 Search in Google Scholar

46 Hurley D. Sharp increase in large-vessel stroke risk seen in young, healthy COVID-19 patients. Neurol Today. 2020;20(10):36–7. http://dx.doi.org/10.1097/01.nt.0000668912.81159.e3 Search in Google Scholar

47 Cascio Rizzo A, Giussani G, Agostoni EC. Ischemic stroke and vaccine-induced immune thrombotic thrombocytopenia following COVID-19 vaccine: A case report with systematic review of the literature. Cerebrovasc Dis. 2022;51(6):722–34. http://dx.doi.org/10.1159/000524290 Search in Google Scholar

48 Trepet G, Radzikhovska N. Ischemic Stroke in COVID-19: A Systematic Review. J Pharm Res Int. 2021;2412–20. http://dx.doi.org/10.9734/jpri/2021/v33i60b34893 Search in Google Scholar

49 Dixon L, Coughlan C, Karunaratne K, Gorgoraptis N, Varley J, Husselbee J, et al. Immunosuppression for intracranial vasculitis associated with SARS-CoV-2: therapeutic implications for COVID-19 cerebrovascular pathology. J Neurol Neurosurg Psychiatry . 2020;92(1):103–4. http://dx.doi.org/10.1136/jnnp-2020-324291 Search in Google Scholar

50 Hernández-Fernández F, Sandoval Valencia H, Barbella-Aponte RA, Collado-Jiménez R, Ayo-Martín Ó, Barrena C, et al. Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description. Brain . 2020;143(10):3089–103. http://dx.doi.org/10.1093/brain/awaa239 Search in Google Scholar

51 Lapergue B, Lyoubi A, Meseguer E, Avram I, Denier C, Venditti L, et al. Large vessel stroke in six patients following SARSCoV-2 infection: a retrospective case study series of acute thrombotic complications on stable underlying atherosclerotic disease. Eur J Neurol . 2020;27(11):2308–11. http://dx.doi.org/10.1111/ene.14466 Search in Google Scholar

52 McAlpine LS, Zubair AS, Maran I, Chojecka P, Lleva P, Jasne AS, et al. Ischemic stroke, inflammation, and endotheliopathy in COVID-19 patients. Stroke . 2021;52(6):e233–8. http://dx.doi.org/10.1161/STROKEAHA.120.031971 Search in Google Scholar

53 Katz JM, Libman RB, Wang JJ, Sanelli P, Filippi CG, Gribko M, et al. Cerebrovascular complications of COVID-19. Stroke . 2020;51(9):e227–31. http://dx.doi.org/10.1161/STROKEAHA.120.031265 Search in Google Scholar

54 Cappellari M, Zini A, Sangalli D, Cavallini A, Reggiani M, Sepe FN, et al. Thrombolysis and bridging therapy in patients with acute ischaemic stroke and Covid-19. Eur J Neurol. 2020;27(12):2641–5. http://dx.doi.org/10.1111/ene.14511 Search in Google Scholar

55 Salahuddin H, Afreen E, Sheikh IS, Lateef S, Dawod G, Daboul J, et al. Neurological predictors of clinical outcomes in hospitalized patients with COVID-19. Front Neurol . 2020;11:585944. http://dx.doi.org/10.3389/fneur.2020.585944 Search in Google Scholar